CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-05 | Hunt Anthony Director | Option exercise | +11,808 | $33.87 | $400K | 151,648 |
| 2024-12-05 | Hunt Anthony Director | Option exercise · Stock Option (Right to Buy) | +11,808 | 8,856 | ||
| 2024-11-21 | Hunt Anthony Director | Option exercise | +24,246 | $33.87 | $821K | 164,086 |
| 2024-11-21 | Hunt Anthony Director | Sale | −24,246 | $139.67 | $3.4M | 139,840 |
| 2024-11-21 | Hunt Anthony Director | Option exercise · Stock Option (Right to Buy) | +24,246 | 0 | ||
| 2024-11-20 | Garland Jason K CFO | Shares withheld for taxes | −367 | $123.41 | $45K | 7,676 |
| 2024-11-20 | Loeillot Olivier Chief Executive Officer | Shares withheld for taxes | −861 | $123.41 | $106K | 32,556 |
| 2024-11-19 | MUIR GLENN P Director | Option exercise | +19,000 | $36.29 | $690K | 32,283 |
| 2024-11-19 | MUIR GLENN P Director | Option exercise · Stock Option (Right to Buy) | −19,000 | 0 | ||
| 2024-09-10 | Hunt Anthony Director | Option exercise 10b5-1 | +10,000 | $33.87 | $339K | 162,031 |
| 2024-09-10 | Hunt Anthony Director | Sale 10b5-1 | −1,495 | $143.77 | $215K | 160,536 |
| 2024-09-10 | Hunt Anthony Director | Sale 10b5-1 | −9,369 | $144.88 | $1.4M | 151,167 |
| 2024-09-10 | Hunt Anthony Director | Sale 10b5-1 | −10,723 | $145.95 | $1.6M | 140,444 |
| 2024-09-10 | Hunt Anthony Director | Sale 10b5-1 | −604 | $146.67 | $89K | 139,840 |
| 2024-09-10 | Hunt Anthony Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 24,246 | ||
| 2024-09-03 | Loeillot Olivier Chief Executive Officer | Grant or award | +17,631 | 33,417 | ||
| 2024-09-03 | Loeillot Olivier Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +16,278 | 16,278 | ||
| 2024-09-03 | Hunt Anthony Director | Returned to the company | −13,146 | 152,031 | ||
| 2024-09-03 | Hunt Anthony Director | Returned to the company · Stock Option (Right to Buy) | −13,057 | 6,528 | ||
| 2024-08-02 | KURIYEL RALF Senior VP, R&D | Sale | −6,973 | $159.36 | $1.1M | 12,288 |
Page 9 of 11 · 215 trades